APA (7th ed.) Citation

N, F., K, T., S, U., A, O., R, O., H, S., . . . S, T. (2022). A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients. Endocrine, 76(1), 70. https://doi.org/10.1007/s12020-021-02963-z

Chicago Style (17th ed.) Citation

N, Fukuda, et al. "A Proposed Clinical Scoring System for Initiation of Lenvatinib Treatment in Radioiodine-refractory Thyroid Cancer Patients." Endocrine 76, no. 1 (2022): 70. https://doi.org/10.1007/s12020-021-02963-z.

MLA (9th ed.) Citation

N, Fukuda, et al. "A Proposed Clinical Scoring System for Initiation of Lenvatinib Treatment in Radioiodine-refractory Thyroid Cancer Patients." Endocrine, vol. 76, no. 1, 2022, p. 70, https://doi.org/10.1007/s12020-021-02963-z.